Mr. KK Chiu is the Chief Executive of Greater China at Cushman & Wakefield, bringing more than 40 years of experience in the real estate industry. He advises clients on comprehensive solutions across the full real estate life cycle. Over the past 30 years, he has been a core leader in developing Cushman & Wakefield’s Greater China business. Previously, he served as Head of Valuation & Advisory, Asia Pacific, where he provided strategic advice for accounting and public listings, real estate planning and development, and business valuation for numerous corporate clients.

Before joining the company (formerly DTZ) in 1993, Mr. Chiu worked at another international consultancy firm for nine years, serving as Director of the Valuation Department.

Mr. Chiu is the Past President and former Chairman of the General Practice Division of The Hong Kong Institute of Surveyors (HKIS) (2015–2017 / 2017–2019). He currently serves as a General Council Member of both HKIS and the China Institute of Real Estate Appraisers. He is also a member of the HKIS Working Group for Valuation Standards and previously served as Chairman of the Board of Membership from 1999 to 2005.

‍

Kam Shing Kwang is Chief Executive Officer, Hong Kong and Chair for North Asia at J.P. Morgan. In addition, she is a member of J.P. Morgan’s Asia Pacific Management Committee.

Ms. Kwang has over 30 years of experience in financial services, across private banking, asset management and investment banking. Since joining J.P. Morgan in 1998, she has played a key role in facilitating partnership across lines of business to better address clients’ corporate balance sheet and personal wealth management needs.

Between 2019 and 2024, Ms. Kwang was Vice Chair of Investment Banking, Greater China. She was also Chief Executive Officer of J.P. Morgan’s Private Bank in Asia from 2017 to 2023.

Between 2016 and 2018, Ms. Kwang completed her first term as Chief Executive Officer for J.P. Morgan Hong Kong, overseeing local governance, coordination and controls. She is a trusted advisor for the industry, having had a seat on Hong Kong’s Banking Advisory Committee from 2016 to 2022, which advises Hong Kong’s Chief Executive on banking sector issues.

Ms. Kwang was also previously named one of the leading female private bankers in Asia by Global Investor Magazine, one of the top twelve most influential female bankers in Asia by Finews.asia, and the most influential female leader in Asia by The Digital Banker.

Ms. Kwang holds a BAcc (Hon) degree from National University of Singapore and the designation of CFA. She is also a member on the Advisory Board for Wealth Management Lee Kong Chian School of Business at Singapore Management University.

‍

Dr. Kenneth Tsang leads the development and drives operational and clinical excellence of IHH's business operations in North Asia which include multi-specialty hospitals, networks of primary, specialist and surgical clinics, as well as ambulatory care centres in Hong Kong and Shanghai. His strategic leadership plays a pivotal role in advancing IHH’s integrated healthcare businesses in China towards sustainable and long-term growth.

In conjunction with his regional role, Dr Tsang provides oversight for Gleneagles Hospital Hong Kong as Chief Executive Officer. He also provides leadership for the clinic network under Gleneagles Healthcare, ambulatory services under Gleneagles MediCentre, and Parkway Laboratory Services in Hong Kong. Dr. Tsang also spearheads Gleneagles Clinical Trials Centre which contributes to healthcare innovation and advancement in Hong Kong and nearby regions.

Prior to joining IHH, Dr. Tsang was with the Hospital Authority in Hong Kong for over 25 years, first as a practising physician in Queen Elizabeth Hospital before becoming a full-time medical administrator at its Head Office, taking up management roles in patient safety, strategy and service planning, infection control and cluster services.

Dr. Tsang is a Fellow of the Hong Kong Academy of Medicine (Community Medicine), a Fellow of the Hong Kong College of Community Medicine and a Fellow of The Royal Australasian College of Medical Administrators. He is also an Honorary Clinical Associate Professor of School of Public Health, Li Ka Shing Faculty of Medicine of The University of Hong Kong.

‍

Lily Yan is a former simultaneous interpreter and senior interpreting instructor, and served as a senior interpreter for the Fortune Global 500 Forum, Shenzhen Institutes of Advanced Technology of the Chinese Academy of Sciences, CICC, BNP Paribas, and FAW-Volkswagen. Ms. Yan joined iFLYTEK in 2018 as Assistant President to iFLYTEK South China Co., Ltd., and later as Head of iFLYTEK Hong Kong and Macau Region. She successively established iFLYTEK Macau and Hong Kong companies, deploying iFlytek's smart education, smart city, and smart healthcare initiatives in Hong Kong and Macau, promoting technological innovation, industrial incubation, and application of artificial intelligence in both regions.

Ling Yang is Co-Head of Asia Healthcare and Head of China at Asia Buyout of the Carlyle Group. She previously worked at KKR & Co. and Goldman Sachs. She holds an MBA from Harvard Business School, and a BA from Smith College.

Mr. Zhai Lingyun is an expert in health industry transformation with over 20 years of leadership experience across healthcare, finance, and retail sectors. He has held senior executive and board leadership roles in multiple multinational corporations, bringing a rich international perspective to his strategic decision-making.

As Chairman and CEO of HealthBaby Biotech, he leads the company in leveraging cord blood and cellular technology as its core advantage and using children's whole-cycle health as the fulcrum, aiming to build a trinity health ecosystem integrating Family, Healthcare, and Enterprise. Extending from life cell storage to cell-level health management, he strives to establish the corporate brand of "Guardian of Life's Beginning."

Mr. Zhai holds a Doctor of Business Administration from The University of Hong Kong and an MBA from the University of Bedfordshire, UK. He is a qualified Senior Economist in China.

‍

Lucas Kong serves as General Manager of KN Group Hong Kong and Global Head of Treasury for KN Group, overseeing global treasury management, tax planning, and capital market initiatives. He holds a Masters in Accountancy from Wake Forest University and the Chartered Financial Analyst (CFA) designation, bringing extensive expertise in corporate banking, capital markets, project management, and wealth investment. His international career includes positions at HSBC Private Banking, J.P. Morgan Private Bank, and HSBC across Hong Kong, London, and mainland China.

Matthew Jung is the CEO of Power S (Hong Kong) Company Limited, the independent international division of Li-Ning Sports. A 28-year marketing and business leader across various sectors, he is overseeing the rapid global expansion of China’s leading sports footwear and apparel brand. Jung has held executive leadership roles at Nike Inc, where he helped double Converse Asia’s business in 3 years, and most recently at Callaway, where he reset, then positioned the sale of its Jack Wolfskin brand. A former U.S. collegiate and Hong Kong professional basketball player and now passionate golf enthusiast, Jung is married and a father of three, all proud to call Hong Kong home.

Michael is the Co-Founder & CEO of Bowtie Life Insurance Company, a mission-driven life and health digital insurer in Hong Kong. He firmly believes in technology's power to simplify the insurance experience, making insurance transparent and truly customer-centric. Under his leadership, the Bowtie team is dedicated to bringing insurance back to its noble purposes – providing protection.

Before launching Bowtie, Michael also co-founded technology startups Coherent and Seasonalife. Michael is a Fellow of the Society of Actuaries (FSA) and a member of the Actuarial Society of Hong Kong (ASHK).

Xia Ming is the founding partner of MWealth, a Singapore-based quantitative trading hedge fund. He previously worked at J.P. Morgan, DBS Asset Management, and Standard Chartered Bank. As an active participant in the capital markets, Ming has assisted multiple companies with listings on the Shanghai, Hong Kong, and New York stock exchanges. Born in Hangzhou, he earned a full Singapore government scholarship at the age of 12, completed his secondary education in Singapore, and later graduated from Nanyang Technological University. Additionally, he is an active rescuer with the United Nations Office for the Coordination of Humanitarian Affairs (UN OCHA), having participated in earthquake rescue missions in Nepal (2015), Turkey (2023), and Myanmar (2025).

Pak-Sun Ting is the founder and CEO of Votee AI, a generative AI platform focused on underserved languages. Votee AI is an Asia-based company with a digital footprint across the region and partnerships across three continents.

Before becoming an entrepreneur, Pak was the Head of Fixed Income at Bank of China (Hong Kong) for close to seven years, where he helped establish both the sales and syndicate teams. Previously, Pak was a Director at Standard Chartered Bank and an Associate at J.P. Morgan. Pak is a Fellow of the Canadian Securities Institute, a Chartered Investment Manager, and received his Bachelor of Administrative Studies from York University in Toronto.

‍

Dr. Philip Pu Zhai, aged 50, obtained a Ph.D from Cambridge University in the United Kingdom in 2000 and a bachelor degree in Material Science and Engineering from Tsinghua University, China, in 1996.

He has been President for Ascendent Capital Partners (Asia) Limited, based in Hong Kong, since October 2018. Ascendent is a private equity firm focused on mid-market Greater China investment opportunities, managing capital for global renowned institutional investors including sovereign wealth funds, endowments, pensions and foundations. Recently, Ascendent Capital Partners completed the acquisition of Hollysys Automation Technologies Ltd and he has been appointed CEO of the Hong Kong office since Oct 2024. Hollysys Automation Technologies manufactures automation and control systems. The company produces process, industrial, rail and subway and nuclear power plant automation equipment.

He has been the Chief Executive Officer of China Alpha Fund Management (HK) Limited since July 2015. Dr. Zhai has worked in the field of investment banking as Managing Director of J.P. Morgan Securities (Asia Pacific) Limited from September 2009 to March 2015, and as Managing Director of Macquarie (Hong Kong) Limited from May 2007 to August 2009. He has over 20 years of experience in corporate development and investment banking in the Greater China market.

Besides career life, he is currently the Director of Dalton Foundation Limited in Hong Kong, the Executive Vice Chairman of Chinese Financial Association of Hong Kong, the Vice President of Tsinghua Alumni Association of Hong Kong and the Director of HK & Macau Taiwanese Charity Fund Limited.

He is also a committee member of Shaanxi Committee of The Chinese People’s Political Consultative Conference. He has been appointed as a member of the Committee on Innovation, Technology and Industry Development since March 2023. He has been appointed as a member of the board of directors of Hong Kong Science & Technology Parks Corporation since July 2023. He has been appointed as a member of the Listing Committee of HKEX since July 2024. He has been appointed as Honorary Advisors of Hong Kong Quality And Talent Migrants Association since 2025.

‍

‍

Pierre‑Yves Buysschaert is the Lufthansa Group’s General Manager for Hong Kong, Macao and South China, overseeing the commercial strategy for SWISS and Lufthansa in one of Asia’s key aviation markets. His career with the Group spans multiple continents — from Europe to the Middle East and now Asia — shaping his global perspective on commercial leadership, partnerships, and customer strategy.

Since moving to Hong Kong in 2025, he has focused on strengthening corporate partnerships, enhancing the region’s premium travel offering, and advancing the Lufthansa Group’s sustainability initiatives across Greater China.